PMC:7795856 / 3444-3661 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"114","span":{"begin":45,"end":48},"obj":"Gene"},{"id":"135","span":{"begin":110,"end":116},"obj":"Disease"}],"attributes":[{"id":"A114","pred":"tao:has_database_id","subj":"114","obj":"Gene:134864"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" immune suppression [7]. Of note, the use of Tα1 has recently undergone reassessment in the context of modern cancer immunotherapies, as there is indication that this peptide may support immune checkpoint inhibition. "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":110,"end":116},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":" immune suppression [7]. Of note, the use of Tα1 has recently undergone reassessment in the context of modern cancer immunotherapies, as there is indication that this peptide may support immune checkpoint inhibition. "}

{"project":"LitCovid-sentences","denotations":[{"id":"T24","span":{"begin":25,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" immune suppression [7]. Of note, the use of Tα1 has recently undergone reassessment in the context of modern cancer immunotherapies, as there is indication that this peptide may support immune checkpoint inhibition. "}